Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine effect on motor evoked potential monitoring during craniotomy
2014-000962-23Phase 4Active
- Sponsor
- Parc de Salut Mar
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine (2 arms), sponsored by Parc de Salut Mar. Primary endpoints: Baseline motor evoked potential threshold intensity and Baseline motor evoked potential amplitude. Started Jun 2014; status: active.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on 2014-000962-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000962-23.